
Brainsway (BWAY) Stock Forecast & Price Target
Brainsway (BWAY) Analyst Ratings
Bulls say
BrainsWay Ltd has demonstrated robust growth in its business model, evidenced by an over 50% increase in equipment utilization rates since the establishment of recent investments. The company has also secured additional strategic investments that position it for accelerating revenue growth, further enhancing its financial prospects. Moreover, the successful initial equity financing transaction has established a favorable template for future financial activities, contributing to a positive outlook for the company's stock performance.
Bears say
BrainsWay Ltd faces several significant risks that contribute to a negative outlook on its stock. Key concerns include a slower-than-expected adoption of its Deep TMS systems, which could hinder revenue growth, as well as challenges in expanding reimbursement options and market access. Additionally, the company's ability to advance clinical indications remains uncertain, compounded by the potential for long-term dilution risk affecting shareholder value.
This aggregate rating is based on analysts' research of Brainsway and is not a guaranteed prediction by Public.com or investment advice.
Brainsway (BWAY) Analyst Forecast & Price Prediction
Start investing in Brainsway (BWAY)
Order type
Buy in
Order amount
Est. shares
0 shares